• Idorsia’s non-GAAP net loss widened 89% year over year to CHF 123 million in the first nine months of 2026.
• Non-GAAP net revenue fell to CHF 166 million, while non-GAAP operating expenses rose 8% year over year to CHF 251 million.
• A proposed commercialization partnership with SPV investors would support a specialist-led launch of TRYVIO/JERAYGO.
• Full-year 2026 guidance remained unchanged for non-GAAP operating expenses of approximately CHF 330 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Idorsia Ltd. published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.